KYNTRA BIO, INC. (KYNB) is a pharmaceutical preparations company, listed on the Nasdaq. With a market capitalization of $29 million, KYNTRA BIO, INC. is a micro-cap company. The stock currently trades at $7.13, up 2.89% today, with a 52-week range of $4.85–$12.60.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.48 | $-0.48 | +83.6% | |
| 2023 | $-2.92 | $-2.92 | +7.0% | |
| 2022 | $-3.14 | $-3.14 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-17 | 0000950170-25-040280 | SEC ↗ |
| 2023-12-31 | 2024-02-26 | 0000950170-24-020161 | SEC ↗ |
| 2022-12-31 | 2023-02-27 | 0000950170-23-004668 | SEC ↗ |
| 2021-12-31 | 2022-02-28 | 0001564590-22-007632 | SEC ↗ |
| 2020-12-31 | 2021-03-01 | 0001564590-21-009871 | SEC ↗ |
| 2019-12-31 | 2020-03-02 | 0001564590-20-008161 | SEC ↗ |
| 2018-12-31 | 2019-02-27 | 0001564590-19-004979 | SEC ↗ |
| 2017-12-31 | 2018-02-27 | 0001564590-18-003508 | SEC ↗ |
| 2016-12-31 | 2017-03-01 | 0001564590-17-003095 | SEC ↗ |
| 2015-12-31 | 2016-02-29 | 0001564590-16-013728 | SEC ↗ |